Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer

被引:1
|
作者
Lin, D. [1 ]
Yang, X. [1 ]
机构
[1] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing, Peoples R China
关键词
PD-L1; Assays; TPS; Non-Small Cell Lung Cancer;
D O I
10.1016/j.jtho.2019.08.1663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.09-14
引用
收藏
页码:S774 / S774
页数:1
相关论文
共 50 条
  • [1] Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
    Fujimoto, Daichi
    Yamashita, Daisuke
    Fukuoka, Junya
    Kitamura, Yuka
    Hosoya, Kazutaka
    Kawachi, Hayato
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Tachikawa, Ryo
    Date, Naoki
    Sakanoue, Ichiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2018, 38 (12) : 6891 - 6895
  • [2] Expression of PD-L1 on Routine Non-Small Cell Lung Carcinoma Sections: Comparative Assessment of SP263 (Ventana) and 22C3 (DAKO pharmDx)
    Quinn, A. M.
    Gosney, J.
    Bishop, P.
    Bloor, R.
    Harreld, C.
    Mcnulty, C.
    Bowden, R.
    Moss, A.
    Forrest, S.
    Montero, A.
    Chaturvedi, A.
    Joseph, L.
    Paiva-Correia, A.
    Doran, H.
    Taniere, P.
    Crosbie, P.
    Blackhall, F.
    Summers, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S761 - S763
  • [3] PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs An Interclone Evaluation by Differently Trained Pathologists
    Munari, Enrico
    Rossi, Giulio
    Zamboni, Giuseppe
    Lunardi, Gianluigi
    Marconi, Marcella
    Sommaggio, Marco
    Netto, George J.
    Hoque, Mohammad O.
    Brunelli, Matteo
    Martignoni, Guido
    Haffner, Michael C.
    Moretta, Francesca
    Pegoraro, Maria C.
    Cavazza, Alberto
    Samogin, Giuseppina
    Furlan, Vanna
    Mariotti, Francesca R.
    Vacca, Paola
    Moretta, Lorenzo
    Bogina, Giuseppe
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (10) : 1384 - 1389
  • [4] PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 Assays
    Dabbagh, Tamara Z.
    Sughayer, Maher A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (06) : 462 - 466
  • [5] External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different
    Dodson, Andrew
    Parry, Suzanne
    Lissenberg-Witte, Birgit
    Haragan, Alex
    Allen, David
    O'Grady, Anthony
    McClean, Emma
    Hughes, Jamie
    Miller, Keith
    Thunnissen, Erik
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (02): : 138 - 145
  • [6] Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation-Positive Lung Adenocarcinoma
    Kim, Taehee
    Cha, Yoon Jin
    Chang, Yoon Soo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (01) : 51 - 60
  • [7] CT-guided transthoracic needle biopsy for evaluation of PD-L1 expression: Comparison of 22C3 and SP263 assays
    Beck, Kyongmin S.
    Kim, Seung Joon
    Kang, Jin Hyoung
    Han, Dae Hee
    Jung, Jung Im
    Lee, Kyo Young
    THORACIC CANCER, 2019, 10 (07) : 1612 - 1618
  • [8] PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays
    Munari, Enrico
    Zamboni, Giuseppe
    Lunardi, Gianluigi
    Marconi, Marcella
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Quatrini, Linda
    Vacca, Paola
    Moretta, Lorenzo
    Bogina, Giuseppe
    HUMAN PATHOLOGY, 2019, 90 : 54 - 59
  • [9] Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
    Marchetti, Antonio
    Barberis, Massimo
    Franco, Renato
    De Luca, Graziano
    Pace, Maria Vittoria
    Staibano, Stefania
    Volante, Marco
    Buttitta, Fiamma
    Guerini-Rocco, Elena
    Righi, Luisella
    D'antuono, Tommaso
    Scagliotti, Giorgio V.
    Pinto, Carmine
    De Rosa, Gaetano
    Papotti, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1654 - 1663
  • [10] Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression in Non-Small-Cell Lung Cancer Using Routine Clinical and Conditioned Archives
    Kim, Sue Youn
    Kim, Tae-Eun
    Park, Chan Kwon
    Yoon, Hyoung-Kyu
    Sa, Young Jo
    Kim, Hyo Rim
    Woo, In Sook
    Kim, Tae-Jung
    CANCERS, 2022, 14 (13)